Inhibition of CXCR1/2 was achieved via treatment of tumor cells in culture with the small molecule inhibitor, SX-682; chemotherapy agents included the alkylating agent cisplatin and the microtubule-targeting agent, docetaxel. The gene discussed is CXCR1; the disease is neoplasm.